Agustin Melo Carrillo MD, PhD. is an instructor of the Department of Anesthesia, Critical Care and Pain Medicine at the Beth Israel Deaconess Medical Center. Harvard Medical School. As a researcher of the Headache Research Center at the Beth Israel, my work focuses on three different lines of research. The first focuses on improving the reliability of animal models of migraine, the second focuses on the relationship between epilepsy and headache and the third focuses on CGRP role in migraine and the mechanisms by which CGRP monoclonal antibodies and antagonists prevent chronic migraine.

• Study of Medicine in Regensburg/Bochum/Bonn/Paris • Thesis in Serotonin pharmacology in Bonn (Manfred Goethert) • Pediatric Training London/Cambridge • PhD University College London (Brian Neville) • Child Neurology Training Hospital for Sick Children in Toronto (Carter Snead) • SUNY Upstate Medical University, Syracuse, NY • Director of Pediatric Headache and Botox Clinic • Duke University Hospital, NC • Director of Pediatric Headache and Botox Clinic • Director of TSC Center of Excellence

Dawn C. Buse PhD is a Clinical Professor of Neurology at Albert Einstein College of Medicine and a licensed psychologist. She has worked with people with migraine and other chronic painful conditions for two decades. She has more than 150 scientific publications and has won 8 US and international research awards and 4 professional awards for her work in the field of migraine. She is a co-investigator on the American Migraine Prevalence and Prevention (AMPP) Study, the Chronic Migraine Epidemiology and Outcomes (CAMEO) Study US and International Studies, the Migraine Signature Study (MSS), the International Burden of Migraine (IBMS) Study, the Migraine, Symptoms and Treatment in America (MAST) Study, the OVERCOME Study, and the FDA sponsored Migraine Clinical Outcome Assessment System (MiCOAS) grant which is gathering patient input for the development of migraine clinical trial endpoints. Dr. Buse provides clinical care to individuals using biobehavioral techniques which include cognitive behavioral therapy, guided visual imagery, biofeedback and mindfulness training.

Professor Debbie Hay PhD, Department of Pharmacology & Toxicology, University of Otago, New Zealand. Debbie has a BSc(Hons) in pharmacology from Sheffield University and PhD from Imperial College London. She is a Fellow of the British Pharmacological Society (FBPhS) and a Fellow of the Royal Society Te Apārangi (FRSNZ). Research in the Hay laboratory focuses on the molecular pharmacology and headache relevance of class B G protein-coupled receptors, including those for CGRP, amylin, the adrenomedullins, PACAP and VIP. Debbie is an Editorial Board member of Trends in Pharmacological Sciences.